<DOC>
	<DOCNO>NCT00620776</DOCNO>
	<brief_summary>The purpose study conduct preliminary evaluation efficacy combine medication psychotherapy generalize anxiety disorder ( GAD ) . The general goal current study conduct late stage treatment development study . The goal stage research provide preliminary answer question gather data estimate intervention parameter ( e.g. , effect size , attrition rate , response rate ) would assist plan research .</brief_summary>
	<brief_title>Combined Treatment Generalized Anxiety Disorder ( GAD )</brief_title>
	<detailed_description>The specific aim study collect preliminary data relevant follow hypothesis : 1 . Primary Hypothesis : Acute phase improvement combine cognitive behavioral therapy ( CBT ) plus medication superior medication alone . 2 . Secondary Hypotheses : Combined CBT plus medication superior medication alone number secondary outcome measure , include core feature GAD ( worry ) , depressive symptom , functional impairment , quality life . 3 . Additional Exploratory Aim : We explore comparative relapse rate combine CBT plus medication treatment medication alone treatment condition 6-month follow-up .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>GAD diagnosis structure interview Hamilton Anxiety Scale score 18 less Clinical Global Impressions Scale score least 4 Hamilton Depression Scale score 18 less Hamilton Depression Scale suicide item score less 2 Use effective form contraception throughout Hypersensitivity venlafaxine XR History seizures Episode major depressive disorder previous 6 month History psychotic illness , bipolar disorder , dementia Substance abuse dependence past 6 month Other anxiety disorder exception social phobia long GAD primary Regular use anxiolytic antidepressant within 7 day study onset Use fluoxetine monoamine oxidase inhibitor within 28 day study onset ( low dose usage benzodiazepine prevent participation ) Use psychotic medication besides benzodiazepine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>Psychotherapy plus medication</keyword>
	<keyword>Combined treatment</keyword>
</DOC>